EastWest Bioscience Balance Sheet Health
Financial Health criteria checks 0/6
EastWest Bioscience has a total shareholder equity of CA$3.4M and total debt of CA$2.5M, which brings its debt-to-equity ratio to 71.7%. Its total assets and total liabilities are CA$7.6M and CA$4.2M respectively.
Key information
71.7%
Debt to equity ratio
CA$2.46m
Debt
Interest coverage ratio | n/a |
Cash | CA$19.97k |
Equity | CA$3.43m |
Total liabilities | CA$4.19m |
Total assets | CA$7.62m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: EAST's short term assets (CA$321.6K) do not cover its short term liabilities (CA$3.8M).
Long Term Liabilities: EAST's short term assets (CA$321.6K) do not cover its long term liabilities (CA$422.3K).
Debt to Equity History and Analysis
Debt Level: EAST's net debt to equity ratio (71.1%) is considered high.
Reducing Debt: EAST's debt to equity ratio has increased from 59.6% to 71.7% over the past 5 years.
Debt Coverage: EAST's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if EAST's interest payments on its debt are well covered by EBIT.